Adjunctive Strategies

Repurposed pharmaceuticals

Metformin · Tamoxifen · Mebendazole · Fenbendazole · Albendazole · Niclosamide · Ivermectin · Hydroxychloroquine · Itraconazole · Doxycycline · Azithromycin · Nitazoxanide · Statins (HMG-CoA reductase inhibitors) · Celecoxib · Disulfiram · Propranolol · Losartan · Candesartan

Nutraceuticals

Melatonin · N-acetylcysteine · Curcumin · Sulforaphane · EGCG · Berberine · Resveratrol · Quercetin · Omega-3 fatty acids · Beta-glucans / medicinal-mushroom polysaccharides

Metabolic interventions

Metformin · AICAR · Berberine · Resveratrol

Anti-inflammatory

Celecoxib · Curcumin · Omega-3 fatty acids

Mitochondrial modulators

Metformin · Niclosamide · Doxycycline · AICAR · Berberine

Redox modulators

Melatonin · N-acetylcysteine · Sulforaphane · EGCG

Angiogenesis-related

Itraconazole · Propranolol

Fibrosis / stroma

Losartan · Candesartan

Immune-modulatory

Azithromycin · Beta-glucans / medicinal-mushroom polysaccharides

Autophagy modulators

Hydroxychloroquine

Apoptosis-related

Mebendazole · Disulfiram

Anti-glycolytic

Metformin · Fenbendazole

Lipid metabolism

Statins (HMG-CoA reductase inhibitors) · Omega-3 fatty acids

Epigenetic modifiers

Sulforaphane

Anti-invasive / anti-metastatic

Doxycycline · Propranolol

This oncology atlas is educational. Pathway maps, adjunctive strategies, and compound listings describe mechanistic relevance. They do not establish clinical efficacy, do not recommend treatment, and are not a substitute for oncology care. Evidence tiers are not equivalent.